[1] |
Guo X,Lin W,Bao J,et al.A Comprehensive cis -eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies[J].Am J Hum Genet,2018,102(5):890-903.
|
[2] |
M JR,S V.BMI1 and PTEN are key determinants of breast cancer therapy:A plausible therapeutic target in breast cancer[J].Gene,2018,678:302-311.
|
[3] |
Sun P,Mu Y,Zhang S.A novel NF-κB/MMP-3 signal pathway involves in the aggressivity of glioma promoted by Bmi-1[J].Tumour Biol,2014,35(12):12721-12727.
|
[4] |
Balkhi S,Mashayekhi F,Salehzadeh A,et al.Matrix metalloproteinase (MMP)-1 and MMP-3 gene variations affect MMP-1 and -3 serum concentration and associates with breast cancer[J].Mol Biol Rep,2020,47(12):9637-9644.
|
[5] |
Zhu S,Zhao D,Yan L,et al.BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1[J].Nat Commun,2018,9(1):500.
|
[6] |
Yan Y,Wang Y,Zhao P,et al.BMI-1 Promotes Self-Renewal of Radio- and Temozolomide(TMZ)-Resistant Breast Cancer Cells[J].Reprod Sci,2017,24(12):1620-1629.
|
[7] |
Zhang J,Sarge KD.Identification of a polymorphism in the RING finger of human Bmi-1 that causes its degradation by the ubiquitinproteasome system[J].FEBS Lett,2009,583:960-964.
|
[8] |
Jiang L,Wu J,Yang Y,et al.Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway[J].BMC Cancer,2012,12:406.
|
[9] |
Wang D,Lou X,Jiang XM,et al.Quercetin protects against inflammation,MMP2 activation and apoptosis induction in rat model of cardiopulmonary resuscitation through modulating Bmi 1 expression[J].Mol Med Rep,2018,18(1):610-616.
|
[10] |
Li X,Yang Z,Song W,et al.Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)2,MMP -9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway[J].Int J Oncol,2013,43(3):793-802.
|
[11] |
Sotiriou C,Pusztai L.Gene-expression signatures in breast cancer[J].N Engl J Med,2009,360(8):790-800.
|
[12] |
Gonzalez-Villasana V,Fuentes-Mattei E,Ivan C,et al.Rac1/Pak1/p38/MMP-2 axis regulates angiogenesis in ovarian cancer[J].Clin Cancer Res,2015,21:2127-2137.
|
[13] |
Suhaimi SA,Chan SC,Rosli R.Matrix Metallopeptidase 3 Polymorphisms:Emerging genetic Markers in Human Breast Cancer Metastasis[J].J Breast Cancer,2020,23(1):1-9.
|
[14] |
Hsiao CL,Liu LC,Shih TC,et al.The Association of Matrix Metalloproteinase-1 Promoter Polymorphisms with Breast Cancer[J].In Vivo,2018,32(3):487-491.
|
[15] |
Oliveira VA,Chagas DC,Amorim JR,et al.Association between matrix metalloproteinase-9 gene polymorphism and breast cancer in Brazilian women[J].Clinics,2020,75:e1762.
|
[16] |
Dofara SG,Chang SL,Diorio C.Gene Polymorphisms and Circulating Levels of MMP-2 and MMP-9:A Review of Their Role in Breast Cancer Risk[J].Anticancer Res,2020,40(7):3619-3631.
|
[17] |
Lei H,Hemminki K,Altieri A,et al.Promoter polymorphisms in matrix metalloproteinases and their inhibitors:few associations with breast cancer susceptibility and progression[J].Breast Cancer Res Treat,2007,103(1):61-69.
|
[18] |
Abd Elmaogoud Ragab Ibrahim F,Essam Elfeky S,Haroun M,et al.Association of matrix metalloproteinases 3 and 9 single nucleotide polymorphisms with breast cancer risk:A case-control study[J].Mol Clin Oncol,2020,13(1):54-62.
|
[19] |
Ghilardi G,Biondi ML,Caputo M,et al.A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility[J].Clin Cancer Res,2002,8(12):3820-3823.
|